Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for NEOGEN CORP, €106k.
Filing timeline
BuySaleJeffrey D. Capello
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +90.0%Entry US$4.92 · Close at T+365 US$9.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeffrey D. Capello: trading record in brief
Jeffrey D. Capello appears in 20 filings, published between January 4, 2019 and October 2, 2026, at three Nasdaq-listed companies: Neogen Corp (9, as Director), Biogen Inc. (6, as EVP & Chief Financial Officer) and Agios Pharmaceuticals, Inc. (5, as Director).
Thirteen lines are option exercises, against 6 grants. The only market trade is a purchase of EUR 88,287 at Neogen Corp, on April 22, 2025. No sale is recorded.
By year: 2 filings in 2019, 4 in 2020, 4 in 2024, a peak of 7 in 2025 and 3 in 2026. Six filings, none of them a purchase or a sale, fall in the last twelve months. Filings are published a median of 2 days after the trade.
Trades by Capello within 30 days of colleagues at Neogen Corp number 1, 1 and 1. All in the same direction. Names in order: Aashima Gupta, Amy M. Rocklin and Catherine E. Woteki.
Companies and markets linked to Jeffrey D. Capello
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
9,804 shares@ US$12.2423.3% of flowRestricted Stock UnitsSEC:0000711377-26-000022:0
2,816 sharesCommon stockSEC:0001439222-26-000105:0
1,976 sharesCommon stockSEC:0001439222-26-000075:0
1,777 shares@ US$6.192.7% of flowCommon StockSEC:0000711377-25-000071:0
2,025 shares@ US$6.193.1% of flowCommon StockSEC:0000711377-25-000060:0
19,769 shares@ US$6.0729.6% of flowCommon StockSEC:0000711377-25-000051:0
2,071 shares@ US$5.632.9% of flowCommon StockSEC:0000711377-25-000037:0
2,120 shares0Common stockSEC:0001439222-25-000059:0
1,977 shares0Common stockSEC:0001439222-25-000045:0
20,712 shares@ US$4.838625.3% of flowCommon StockSEC:0000711377-25-000007:0
Canonical exit: 21 Jul 2025 (T+90)
1,776 shares@ US$13.816.5% of flowCommon StockSEC:0000711377-24-000051:0
6,075 shares@ US$13.5821.8% of flowRestricted Stock UnitsSEC:0000711377-24-000039:0
2,070 shares@ US$15.078.1% of flowCommon StockSEC:0000711377-24-000028:0
1,976 shares0Common stockSEC:0001439222-24-000075:0
614 shares@ US$331.7663.7% of flowCommon StockSEC:0001127602-20-005773:1
1,919 shares0Common StockSEC:0001127602-20-005773:0
1,302 shares0Common StockSEC:0001127602-20-001123:0
406 shares@ US$294.2026.4% of flowCommon StockSEC:0001127602-20-001123:1
1,331 shares0Common StockSEC:0001127602-19-001282:0
414 shares@ US$304.6927.3% of flowCommon StockSEC:0001127602-19-001282:1
20 of 20 declarations
